CLINICAL_TRIALS
ClinicalTrials.gov record update
Safety and Efficacy Study of Novel CAR-T Cell Therapy in the Treatment of Hematopoietic and Lymphoid Malignancies
This page presents selected fields from the linked source record. It does not add a medical interpretation.
Record identity and dates
- Source
- ClinicalTrials.gov
- Source record ID
- NCT05513612
- Title field or adapter rule
- protocolSection.identificationModule.officialTitle
- Ingested At
- 2026-04-28T10:39:17.962081+00:00
- Published At
- 2023-03-01T00:00:00+00:00
- Record Updated At
- 2023-03-01
- Timestamp Basis
- source retrieval time was not retained by the feed adapter
- Date limitation
- source retrieval time was not retained by the feed adapter
Fields recorded by this source
- protocolSection.conditionsModule.conditions
["Acute Myeloid Leukemia (AML)", "B-cell Non-Hodgkin\u0027s Lymphoma (B-NHL)", "Multiple Myeloma (MM)", "T-Cell Leukemia/Lymphoma, Adult", "B-cell Acute Lymphoblastic Leukemia (B-ALL)"]- protocolSection.statusModule.lastUpdatePostDateStruct.date
"2023-03-01"- protocolSection.identificationModule.nctId
"NCT05513612"- protocolSection.identificationModule.officialTitle
"Safety and Efficacy Study of Novel CAR-T Cell Therapy in the Treatment of Hematopoietic and Lymphoid Malignancies"- protocolSection.statusModule.overallStatus
"WITHDRAWN"- protocolSection.designModule.phases
["PHASE1"]- protocolSection.statusModule.resultsFirstPostDateStruct.date
""
Study condition terms
Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.
This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.